Time New York: Thu 26 Apr 05:11 am  |  Save 15% on H&R Block Online


PepsiCo (PEP) Tops Q2 Earnings & Revenue Estimates


PepsiCo, Inc. PEP is one of the largest food and beverage business in North America and the second largest in the world. The company boasts a diverse portfolio, both geographically and product wise. Its principal brands/businesses include: Frito-Lay snacks, Pepsi-Cola beverages, Gatorade sports drinks, Tropicana juices and Quaker foods. The company has the competitive advantage of selling both snacks and beverages which are complementary food categories.

However, growing health and wellness consciousness is hurting carbonated soft drinks or CSD category growth.

Investors should note that the earnings estimate for PEP have moved south over the past 30 days for the current year. That said, PEP has an impressive track record in the earnings season. It has delivered positive earnings surprises in all the past four quarters, bringing the average to a positive surprise of 4.57%.

Pepsico, Inc. Price and EPS Surprise

Pepsico, Inc. Price and EPS Surprise | Pepsico, Inc. Quote

Currently, PEP has a Zacks Rank #3 (Hold), but that could definitely change following Pepsi’s earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: PEP beat earnings. Our consensus earnings estimate called for EPS of $1.40/share, and the company reported core EPS of $1.50/share.

Revenues: PEP reported revenues of $15.71 billion. This surpassed our consensus estimate of $15.64 billion.

Key Stats to Note: Revenues increased 3.1% on an organic basis, higher than 2.1% in the previous quarter.

Stock Price: Shares rose 1.51% in pre-market trading at the time of writing.

Check back later for our full write up on this PEP earnings report later!

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.